Twist Bioscience (TWST) Current Assets (2018 - 2026)

Twist Bioscience has disclosed Current Assets across 9 years of filings, most recently posting $323.4 million for Q1 2026.

• In Q1 2026, Current Assets fell 4.43% year-over-year to $323.4 million; the TTM figure through Mar 2026 stood at $323.4 million (down 4.43% YoY), while the FY2025 annual figure was $333.0 million, down 3.98% from the prior year.
• Current Assets advanced to $323.4 million in Q1 2026, from $303.9 million in the prior quarter.
• Over the last five years, Current Assets for TWST reached as high as $664.4 million in Q1 2022 and fell as low as $303.9 million in Q4 2025.
• The 5-year median for Current Assets is $371.9 million (2024), against an average of $425.9 million.
• Annual changes were most pronounced in 2022 — Current Assets surged 40.74% — and 2023, when it slipped 28.87%.
• A 5-year view of Current Assets shows it stood at $541.9 million in 2022, then decreased by 27.98% to $390.2 million in 2023, then dropped by 11.51% to $345.3 million in 2024, then dropped by 12.0% to $303.9 million in 2025, then gained by 6.44% to $323.4 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $323.4 million, $303.9 million, and $333.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.